LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcom… Read more
LENSAR Inc (LNSR) - Total Liabilities
Latest total liabilities as of September 2025: $82.33 Million USD
Based on the latest financial reports, LENSAR Inc (LNSR) has total liabilities worth $82.33 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
LENSAR Inc - Total Liabilities Trend (2018–2024)
This chart illustrates how LENSAR Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
LENSAR Inc Competitors by Total Liabilities
The table below lists competitors of LENSAR Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KG Mobilians Co. Ltd
KQ:046440
|
Korea | ₩209.87 Billion |
|
Arizona Metals Corp
OTCQX:AZMCF
|
USA | $1.44 Million |
|
Aero Win Technology Corp
TW:8222
|
Taiwan | NT$1.24 Billion |
|
Silitech Technology Corp
TW:3311
|
Taiwan | NT$1.48 Billion |
|
LapWall Oyj
HE:LAPWALL
|
Finland | €22.61 Million |
|
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
|
USA | $10.85 Million |
|
Hites S.A.
SN:HITES
|
Chile | CL$262.16 Billion |
|
Oneview Healthcare PLC
PINK:ONVVF
|
USA | $12.71 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down LENSAR Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -6.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LENSAR Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LENSAR Inc (2018–2024)
The table below shows the annual total liabilities of LENSAR Inc from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $47.65 Million | +112.64% |
| 2023-12-31 | $22.41 Million | +61.68% |
| 2022-12-31 | $13.86 Million | +19.63% |
| 2021-12-31 | $11.59 Million | -2.72% |
| 2020-12-31 | $11.91 Million | -81.70% |
| 2019-12-31 | $65.09 Million | +31.89% |
| 2018-12-31 | $49.35 Million | -- |